Updates

Get Alerts
With a free MyAccess profile, you can sign up to receive an email alert when new content is published on this site.
June 20, 2022 | PPP Updates
Newly Approved and Updated Vaccines in 2021
Sarah Talley, PharmD, MPH, Melanie Rae Schrack, PharmD, Lacie McKamey, PharmD, BCPS, BCIDP
June 20, 2022 | PPP Updates
FDA Approves Wegovy (semaglutide) for Chronic Weight Management in Adults
Chelsa L. Deanes, Pharm.D., BCMAS, Clinical Pharmacist Fellow in Drug Information
May 23, 2022 | PPP Updates
Updates in the Recommendations for Pneumococcal Vaccination in Adults
Mary K. Vance, PharmD, PGY1 Pharmacy Practice Resident, Kayla R. Stover, PharmD, FCCP, FIDSA, BCIDP, BCPS, Associate Professor of Pharmacy Practice
May 23, 2022 | PPP Updates
Inclusion of Finerenone (Kerendia) in the 2022 American Diabetes Association Guidelines for Diabetes and Chronic Kidney Disease
Nicole Cheung, PharmD, BCPS; Assistant Professor, Pharmacy Practice, Cerris Chung, PharmD, BCACP; Collaborative Drug Therapy Management Pharmacist, Lauren Woody, PharmD Candidate 2022
May 9, 2022 | PPP Updates
Lybalvi® Use in Patients with Bipolar I Disorder and Schizophrenia
Alexander Vega, Fourth Year PharmD Candidate, Soheyla Mahdavian-Matthews, PharmD, BCGP, Professor, Pharmacy Practice, Amy Renaud, PharmD, TTS, Assistant Professor, Pharmacy Practice
May 9, 2022 | PPP Updates
Pediatric Growth Deficiency 2021 FDA Novel Drugs
Austin Mondloch, PharmD, Matthew Sherman, PharmD, MBA, Genevieve Lynn Ness, PharmD
May 6, 2022 | PPP Updates
Tezepelumab (Tezspire) in Adolescents and Adults with Severe Asthma
Valerie Marcellus, PharmD, BCACP, Assistant Professor, Pharmacy Practice, Nicole Cheung, PharmD, BCPS, Assistant Professor, Pharmacy Practice
May 6, 2022 | PPP Updates
Opdualag™ Approved for Unresectable or Metastatic Melanoma
Jill M. Kolesar, PharmD, MS, College of Pharmacy, University of Kentucky, Lexington, KY
March 31, 2022 | PPP Updates
Tofacitinib for Active Polyarticular Juvenile Idiopathic Arthritis
Nicole Cheung, PharmD, BCPS, Assistant Professor, Pharmacy Practice, Ukamaka Diké Smith, PharmD, MBA, ACUE, Assistant Professor, Pharmacy Practice, Patty Ghazvini, PharmD, BCGP, Division Director and Professor of Pharmacy Practice
March 31, 2022 | PPP Updates
Drug Updates in Lupus
Aubrey Dusch, PharmD, Cassandra Dolecki, PharmD, MBA, BCACP, TTS
January 26, 2022 | PPP Updates
2021 Clinical Guideline Updates for Managing Clostridioides difficile Infection in Adults
Benjamin Tabor, PharmD, P. Brandon Bookstaver, PharmD, FCCP, FIDSA
January 5, 2022 | PPP Updates
Update to Acromegaly Management Guidelines
Christina M. Polomoff, PharmD, BCACP, BCGP, Devra K. Dang, PharmD, BCPS, CDCES, FNAP, Judy T. Chen, PharmD, BCPS, BCACP, CDCES, FNAP
January 5, 2022 | PPP Updates
Tisotumab Vedotin-tftv (Tivdak) Approved for Recurrent or Metastatic Cervical Cancer
Lauren Dietz, PharmD candidate, Jill M. Kolesar, PharmD, MS
January 4, 2022 | PPP Updates
Ponesimod (Ponvory): The Fourth S1P Receptor Modulator Approved for Relapsing Forms of Multiple Sclerosis
Tuyen B. Nguyen, PharmD, MPH, Kelly C. Lee, PharmD, MAS, FCCP, BCPP
November 3, 2021 | PPP Updates
Network Meta-Analysis of the Effectiveness and Safety of NSAIDs and Opioids for Knee and Hip Osteoarthritis
Terry L. Schwinghammer, PharmD, FCCP, FASHP, FAPhA
November 3, 2021 | PPP Updates
Topical minocycline foam (Amzeeq) approved to treat acne vulgaris
Jenna M. Mills, PharmD
October 15, 2021 | PPP Updates
Aducanumab-avwa (Aduhelm): A Novel Therapy for Mild Alzheimer Disease
Casey M. Tiefenthaler, PharmD, Kelly C. Lee, PharmD, MAS, FCCP, BCPP
September 9, 2021 | PPP Updates
Amivantamab Approved for Treatment of EGFR exon 20 insertion-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer
Jill M. Kolesar, PharmD, MS
September 3, 2021 | PPP Updates
Dual Antiplatelet Therapy Duration after Percutaneous Coronary Interventions
Kelly C. Rogers, Pharm.D., BCCP, FCCP, FACC
August 5, 2021 | PPP Updates
Lifestyle Changes that Reduce Symptoms of Gastroesophageal Reflux Disease (GERD)
Terry L. Schwinghammer, PharmD, FCCP, FASHP, FAPhA
August 5, 2021 | PPP Updates
Cabotegravir/Rilpivirine Approved for Treatment of Stable HIV Patients as Extended-Release Antiretroviral Regimen
Y. Vivian Tsai, PharmD, Caroline Derrick, PharmD, BCPS
July 23, 2021 | PPP Updates
Viloxazine (Qelbree): A New Non-Stimulant Medication for Pediatric ADHD
Kevin Kavanagh, PharmD
June 15, 2021 | PPP Updates
Sotorasib Approved for Treatment KRAS G12C-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer
Jill M. Kolesar, PharmD, MS
June 15, 2021 | PPP Updates
New Guidelines for Selection of Glucose-lowering Medication in Type 2 Diabetes
Julie M. Sease, PharmD, FCCP, BCPS, CDCES, BCACP
May 27, 2021 | PPP Updates
FDA Issues Another Safety Alert for the Janus-Kinase Inhibitor Tofacitinib (Xeljanz)
Terry L. Schwinghammer, PharmD, FCCP, FASHP, FAPhA